SEC Form 4 research
| Issuer | Relay Therapeutics, Inc. |
|---|---|
| Tickers | RLAY |
| Reporting owners | 32 |
| Officers and directors | 9 |
| Last public filing | 2026-10-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-08 | 2026-10-07 | Patel Sanjiv | S | 48,199 | $18.1 | Not reported |
| 2026-10-08 | 2026-10-06 | Catinazzo Thomas | S | 206 | $19.26 | Not reported |
| 2026-10-08 | 2026-10-06 | Catinazzo Thomas | S | 17,511 | $18.58 | Not reported |
| 2026-09-09 | 2026-09-08 | Bergstrom Donald A | S | 8,530 | $18.97 | Not reported |
| 2026-09-09 | 2026-09-08 | Catinazzo Thomas | S | 17,717 | $18.94 | Not reported |
| 2026-09-09 | 2026-09-08 | Patel Sanjiv | S | 48,199 | $18.94 | Not reported |
| 2026-08-28 | 2026-08-25 | SB INVESTMENT ADVISERS (UK) LTD, SOFTBANK VISION FUND (AIV M2) L.P., SVF Pauling (Cayman) Ltd | S | 6,000,000 | $19.4 | Not reported |
| 2026-08-28 | 2026-08-26 | Rahmer Peter | S | 4,508 | $20.03 | Not reported |
| 2026-08-18 | 2026-08-17 | Patel Sanjiv | S | 48,199 | $20.33 | Not reported |
| 2026-08-18 | 2026-08-14 | Catinazzo Thomas | S | 17,717 | $19.74 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.